25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Gilead Sciences Inc
Buy, Hold or Sell?

Let's analyze Gilead together

I guess you are interested in Gilead Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Gilead Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Gilead Sciences Inc

I send you an email if I find something interesting about Gilead Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Gilead (30 sec.)










1.2. What can you expect buying and holding a share of Gilead? (30 sec.)

How much money do you get?

How much money do you get?
$3.08
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$14.54
Expected worth in 1 year
$12.32
How sure are you?
82.5%

+ What do you gain per year?

Total Gains per Share
$0.86
Return On Investment
1.0%

For what price can you sell your share?

Current Price per Share
$89.84
Expected price per share
$81.83 - $
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Gilead (5 min.)




Live pricePrice per Share (EOD)
$89.84
Intrinsic Value Per Share
$13.55 - $43.06
Total Value Per Share
$28.10 - $57.60

2.2. Growth of Gilead (5 min.)




Is Gilead growing?

Current yearPrevious yearGrowGrow %
How rich?$18.1b$21b-$914.5m-4.5%

How much money is Gilead making?

Current yearPrevious yearGrowGrow %
Making money$263.2m$1.3b-$1.1b-420.8%
Net Profit Margin3.0%19.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Gilead (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Gilead?

Welcome investor! Gilead's management wants to use your money to grow the business. In return you get a share of Gilead.

First you should know what it really means to hold a share of Gilead. And how you can make/lose money.

Speculation

The Price per Share of Gilead is $89.84. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gilead.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gilead, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $14.54. Based on the TTM, the Book Value Change Per Share is $-0.56 per quarter. Based on the YOY, the Book Value Change Per Share is $0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.77 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gilead.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.291.4%0.200.2%1.091.2%0.610.7%1.221.4%
Usd Book Value Change Per Share0.550.6%-0.56-0.6%0.180.2%-0.16-0.2%0.120.1%
Usd Dividend Per Share0.780.9%0.770.9%0.740.8%0.720.8%0.770.9%
Usd Total Gains Per Share1.321.5%0.210.2%0.931.0%0.560.6%0.891.0%
Usd Price Per Share68.61-74.45-76.90-70.21-76.38-
Price to Earnings Ratio13.29-9.11-19.13-63.87-205.63-
Price-to-Total Gains Ratio51.83-35.89-93.76-74.12-56.29-
Price to Book Ratio4.72-4.66-4.60-4.38-5.36-
Price-to-Total Gains Ratio51.83-35.89-93.76-74.12-56.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share89.84
Number of shares11
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.770.72
Usd Book Value Change Per Share-0.56-0.16
Usd Total Gains Per Share0.210.56
Gains per Quarter (11 shares)2.356.12
Gains per Year (11 shares)9.4224.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
134-24-132-714
268-49863-1438
3102-731795-2262
4136-9826127-2986
5169-12235158-36110
6203-14744190-43134
7237-17153222-50158
8271-19662253-58182
9305-22071285-65206
10339-24580317-72230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%17.03.00.085.0%36.04.00.090.0%85.043.00.066.4%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%12.08.00.060.0%26.014.00.065.0%76.052.00.059.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%53.00.075.041.4%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%33.07.00.082.5%85.043.00.066.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Gilead Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.547-0.556+202%0.181+202%-0.164+130%0.117+368%
Book Value Per Share--14.54416.087-10%16.713-13%16.090-10%15.154-4%
Current Ratio--1.1421.255-9%1.289-11%1.777-36%2.644-57%
Debt To Asset Ratio--0.6600.657+1%0.6630%0.674-2%0.655+1%
Debt To Equity Ratio--1.9361.921+1%1.965-1%2.088-7%1.9430%
Dividend Per Share--0.7770.770+1%0.745+4%0.720+8%0.770+1%
Eps--1.2900.205+531%1.087+19%0.615+110%1.217+6%
Free Cash Flow Per Share--0.9551.377-31%1.769-46%1.684-43%1.982-52%
Free Cash Flow To Equity Per Share---1.405-0.007-99%0.544-358%0.597-335%0.871-261%
Gross Profit Margin--1.0000.855+17%0.881+13%0.947+6%0.974+3%
Intrinsic Value_10Y_max--43.057--------
Intrinsic Value_10Y_min--13.554--------
Intrinsic Value_1Y_max--7.416--------
Intrinsic Value_1Y_min--5.815--------
Intrinsic Value_3Y_max--19.918--------
Intrinsic Value_3Y_min--13.714--------
Intrinsic Value_5Y_max--29.571--------
Intrinsic Value_5Y_min--17.437--------
Market Cap111849897287.680+23%85831110000.00093280500000.000-8%96971180000.000-11%88479161500.000-3%102405649212.500-16%
Net Profit Margin--0.2320.030+683%0.198+17%0.108+115%0.235-1%
Operating Margin--0.3870.338+14%0.349+11%0.304+27%0.409-5%
Operating Ratio--0.6130.633-3%0.643-5%0.685-11%0.575+7%
Pb Ratio6.177+24%4.7174.665+1%4.601+3%4.378+8%5.361-12%
Pe Ratio17.409+24%13.2959.105+46%19.126-30%63.866-79%205.635-94%
Price Per Share89.840+24%68.61074.453-8%76.895-11%70.206-2%76.384-10%
Price To Free Cash Flow Ratio23.513+24%17.95614.047+28%11.397+58%11.152+61%10.573+70%
Price To Total Gains Ratio67.868+24%51.83035.894+44%93.764-45%74.123-30%56.290-8%
Quick Ratio--0.9541.079-12%1.246-23%1.941-51%3.022-68%
Return On Assets--0.0300.003+761%0.022+37%0.012+161%0.033-9%
Return On Equity--0.0880.003+3008%0.065+36%0.035+156%0.089-1%
Total Gains Per Share--1.3240.214+518%0.926+43%0.556+138%0.887+49%
Usd Book Value--18195000000.00020160250000.000-10%21074750000.000-14%20283900000.000-10%19875690250.000-8%
Usd Book Value Change Per Share--0.547-0.556+202%0.181+202%-0.164+130%0.117+368%
Usd Book Value Per Share--14.54416.087-10%16.713-13%16.090-10%15.154-4%
Usd Dividend Per Share--0.7770.770+1%0.745+4%0.720+8%0.770+1%
Usd Eps--1.2900.205+531%1.087+19%0.615+110%1.217+6%
Usd Free Cash Flow--1195000000.0001724250000.000-31%2231000000.000-46%2123600000.000-44%2669104400.000-55%
Usd Free Cash Flow Per Share--0.9551.377-31%1.769-46%1.684-43%1.982-52%
Usd Free Cash Flow To Equity Per Share---1.405-0.007-99%0.544-358%0.597-335%0.871-261%
Usd Market Cap111849897287.680+23%85831110000.00093280500000.000-8%96971180000.000-11%88479161500.000-3%102405649212.500-16%
Usd Price Per Share89.840+24%68.61074.453-8%76.895-11%70.206-2%76.384-10%
Usd Profit--1614000000.000263250000.000+513%1371000000.000+18%778600000.000+107%1683431850.000-4%
Usd Revenue--6949000000.0006950000000.0000%6845500000.000+2%6575450000.000+6%6677345800.000+4%
Usd Total Gains Per Share--1.3240.214+518%0.926+43%0.556+138%0.887+49%
 EOD+4 -4MRQTTM+17 -19YOY+20 -165Y+20 -1610Y+14 -22

3.3 Fundamental Score

Let's check the fundamental score of Gilead Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.409
Price to Book Ratio (EOD)Between0-16.177
Net Profit Margin (MRQ)Greater than00.232
Operating Margin (MRQ)Greater than00.387
Quick Ratio (MRQ)Greater than10.954
Current Ratio (MRQ)Greater than11.142
Debt to Asset Ratio (MRQ)Less than10.660
Debt to Equity Ratio (MRQ)Less than11.936
Return on Equity (MRQ)Greater than0.150.088
Return on Assets (MRQ)Greater than0.050.030
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Gilead Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5069.876
Ma 20Greater thanMa 5087.272
Ma 50Greater thanMa 10084.011
Ma 100Greater thanMa 20077.917
OpenGreater thanClose89.490
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Gilead Sciences Inc

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Fundamental data was last updated by Penke on 2024-10-24 15:59:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Gilead earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Gilead to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 23.2% means that $0.23 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gilead Sciences Inc:

  • The MRQ is 23.2%. The company is making a huge profit. +2
  • The TTM is 3.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ23.2%TTM3.0%+20.3%
TTM3.0%YOY19.8%-16.9%
TTM3.0%5Y10.8%-7.8%
5Y10.8%10Y23.5%-12.7%
4.3.1.2. Return on Assets

Shows how efficient Gilead is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gilead to the Drug Manufacturers - General industry mean.
  • 3.0% Return on Assets means that Gilead generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gilead Sciences Inc:

  • The MRQ is 3.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.0%TTM0.3%+2.7%
TTM0.3%YOY2.2%-1.8%
TTM0.3%5Y1.2%-0.8%
5Y1.2%10Y3.3%-2.2%
4.3.1.3. Return on Equity

Shows how efficient Gilead is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gilead to the Drug Manufacturers - General industry mean.
  • 8.8% Return on Equity means Gilead generated $0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gilead Sciences Inc:

  • The MRQ is 8.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 0.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ8.8%TTM0.3%+8.5%
TTM0.3%YOY6.5%-6.2%
TTM0.3%5Y3.5%-3.2%
5Y3.5%10Y8.9%-5.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Gilead Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Gilead is operating .

  • Measures how much profit Gilead makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gilead to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 38.7% means the company generated $0.39  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gilead Sciences Inc:

  • The MRQ is 38.7%. The company is operating very efficient. +2
  • The TTM is 33.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ38.7%TTM33.8%+4.9%
TTM33.8%YOY34.9%-1.1%
TTM33.8%5Y30.4%+3.4%
5Y30.4%10Y40.9%-10.4%
4.3.2.2. Operating Ratio

Measures how efficient Gilead is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.61 means that the operating costs are $0.61 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Gilead Sciences Inc:

  • The MRQ is 0.613. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.633. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.613TTM0.633-0.020
TTM0.633YOY0.643-0.010
TTM0.6335Y0.685-0.052
5Y0.68510Y0.575+0.110
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Gilead Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Gilead is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.14 means the company has $1.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Gilead Sciences Inc:

  • The MRQ is 1.142. The company is just able to pay all its short-term debts.
  • The TTM is 1.255. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.142TTM1.255-0.113
TTM1.255YOY1.289-0.034
TTM1.2555Y1.777-0.522
5Y1.77710Y2.644-0.868
4.4.3.2. Quick Ratio

Measures if Gilead is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gilead to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.95 means the company can pay off $0.95 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gilead Sciences Inc:

  • The MRQ is 0.954. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.079. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.954TTM1.079-0.125
TTM1.079YOY1.246-0.167
TTM1.0795Y1.941-0.862
5Y1.94110Y3.022-1.081
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Gilead Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Gilead assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gilead to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.66 means that Gilead assets are financed with 66.0% credit (debt) and the remaining percentage (100% - 66.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Gilead Sciences Inc:

  • The MRQ is 0.660. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.657. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.660TTM0.657+0.004
TTM0.657YOY0.663-0.006
TTM0.6575Y0.674-0.017
5Y0.67410Y0.655+0.019
4.5.4.2. Debt to Equity Ratio

Measures if Gilead is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gilead to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 193.6% means that company has $1.94 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gilead Sciences Inc:

  • The MRQ is 1.936. The company is just able to pay all its debts with equity.
  • The TTM is 1.921. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.936TTM1.921+0.014
TTM1.921YOY1.965-0.044
TTM1.9215Y2.088-0.167
5Y2.08810Y1.943+0.145
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Gilead generates.

  • Above 15 is considered overpriced but always compare Gilead to the Drug Manufacturers - General industry mean.
  • A PE ratio of 13.29 means the investor is paying $13.29 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gilead Sciences Inc:

  • The EOD is 17.409. Based on the earnings, the company is fair priced.
  • The MRQ is 13.295. Based on the earnings, the company is underpriced. +1
  • The TTM is 9.105. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD17.409MRQ13.295+4.114
MRQ13.295TTM9.105+4.189
TTM9.105YOY19.126-10.021
TTM9.1055Y63.866-54.760
5Y63.86610Y205.635-141.769
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gilead Sciences Inc:

  • The EOD is 23.513. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 17.956. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 14.047. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD23.513MRQ17.956+5.556
MRQ17.956TTM14.047+3.909
TTM14.047YOY11.397+2.650
TTM14.0475Y11.152+2.896
5Y11.15210Y10.573+0.579
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Gilead is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 4.72 means the investor is paying $4.72 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Gilead Sciences Inc:

  • The EOD is 6.177. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.717. Based on the equity, the company is fair priced.
  • The TTM is 4.665. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD6.177MRQ4.717+1.460
MRQ4.717TTM4.665+0.053
TTM4.665YOY4.601+0.064
TTM4.6655Y4.378+0.287
5Y4.37810Y5.361-0.984
4.6.2. Total Gains per Share

2.4. Latest News of Gilead Sciences Inc

Does Gilead Sciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Gilead Sciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2024-10-21
18:28
Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 WeeksRead
2024-10-19
23:09
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48Read
2024-10-19
17:57
Goldman Sachs: Gilead Sciences, Inc. (NASDAQ:GILD) Is A Stock With High Consensus ROERead
2024-10-18
20:34
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatmentRead
2024-10-18
14:50
Gilead withdraws bladder cancer drug in US after failed trialRead
2024-10-18
12:02
High Growth Tech Stocks to Watch in October 2024Read
2024-10-17
15:00
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should KnowRead
2024-10-14
16:01
How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your PocketRead
2024-10-11
01:22
Is Gilead Sciences, Inc. (NASDAQ:GILD) The Most Popular Stock Among Mutual Funds According To Goldman Sachs?Read
2024-10-09
22:05
Gilead Sciences to Release Third Quarter 2024 Financial Results on Wednesday, November 6, 2024Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Gilead Sciences Inc.

4.8.1. Institutions holding Gilead Sciences Inc

Institutions are holding 87.713% of the shares of Gilead Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc9.68940.1873120632023-1899004-1.5498
2024-06-30Vanguard Group Inc9.2580.15191152617745291990.4612
2024-06-30Capital World Investors6.12450.853176249819-8247585-9.7608
2024-06-30Capital Research Global Investors4.85370.909760427714-818652-1.3367
2024-06-30State Street Corp4.76550.17795932991516249872.816
2024-06-30Dodge & Cox2.66041.363933122337-45150-0.1361
2024-06-30Geode Capital Management, LLC2.1660.162269664496170942.342
2024-06-30Wellington Management Company LLP1.84220.280922935083236733111.5099
2024-06-30Morgan Stanley - Brokerage Accounts1.55320.102719337304-16689864-46.3258
2024-06-30FMR Inc1.48450.0812184821588936365.0808
2024-06-30NORGES BANK1.39670.17821738905713216128.2254
2024-06-30Bank of New York Mellon Corp1.13560.183914138152-535335-3.6483
2024-06-30Northern Trust Corp1.04180.149912970164-259104-1.9586
2024-06-30Legal & General Group PLC0.99710.190712414268930680.7553
2024-06-30Amundi0.90290.28811240529173991318.3137
2024-06-30UBS Asset Mgmt Americas Inc0.89480.219311139775161493416.955
2024-06-30Dimensional Fund Advisors, Inc.0.83630.1866104124132682082.644
2024-06-30Amvescap Plc.0.80860.146110067622-1212343-10.7478
2024-06-30Goldman Sachs Group Inc0.73730.10659179814398927576.8567
2024-06-30Pacer Advisors, INC.0.63371.22677889663284301156.3346
Total 53.78227.1465669586033-11804769-1.8%

4.9.2. Funds holding Gilead Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-08-31Vanguard Total Stock Mkt Idx Inv3.16650.1811394224471339000.3408
2024-08-31Vanguard Institutional 500 Index Trust2.61760.2076325894822574270.7962
2024-09-30American Funds Income Fund of Amer A2.50322.023531164212-335000-1.0635
2024-09-30Dodge & Cox Stock I1.95751.76832437111200
2024-09-30Invesco QQQ Trust1.93980.687824150610-160160-0.6588
2024-09-30Capital Group Wash Mutual Invtrs Comp1.80930.98142252575715025787.1472
2024-09-30American Funds Washington Mutual A1.80930.98142252575715025787.1472
2024-09-30American Funds Capital Income Bldr A1.28891.2167160465583301512.1007
2024-09-30Capital Group American Mutual Comp1.26091.2503156985723970622.5949
2024-09-30American Funds American Mutual A1.26091.2503156985723970622.5949
2024-08-31Fidelity 500 Index1.23280.2071153487011189070.7808
2024-09-30SPDR® S&P 500® ETF Trust1.21080.213815073921-60922-0.4025
2024-09-30iShares Core S&P 500 ETF1.09180.213913592231448960.3314
2024-06-30Vanguard Equity-Income Inv0.99671.527612408369143842913.1125
2024-09-30American Funds American Balanced A0.96770.4251204823100
2024-09-30Capital Group Investment Co of Amer Comp0.87620.5985109091403901283.7088
2024-09-30American Funds Invmt Co of Amer A0.87620.5985109091403901283.7088
2024-08-31Vanguard Value Index Inv0.82890.445810320098723840.7063
2024-09-30The Health Care Select Sector SPDR® ETF0.73941.84619205391-31832-0.3446
2024-09-30Capital Group World Growth & Inc Cmp0.6980.56348690313-361673-3.9955
Total 29.132417.1881362698614+6026043+1.7%

5.3. Insider Transactions

Insiders are holding 0.119% of the shares of Gilead Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-10-01Merdad ParseySELL200083.83
2024-09-12Johanna MercierSELL2935783.78
2024-08-13Johanna MercierSELL549073.98
2024-07-01Merdad ParseySELL200068.63
2024-04-01Merdad ParseySELL200072.96
2024-02-28Merdad ParseySELL200073.18
2024-01-16Andrew D DickinsonSELL500085.78
2024-01-09Johanna MercierSELL824285.23
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets53,579,000
Total Liabilities35,384,000
Total Stockholder Equity18,281,000
 As reported
Total Liabilities 35,384,000
Total Stockholder Equity+ 18,281,000
Total Assets = 53,579,000

Assets

Total Assets53,579,000
Total Current Assets12,317,000
Long-term Assets41,262,000
Total Current Assets
Cash And Cash Equivalents 2,772,000
Short-term Investments 1,426,000
Net Receivables 4,663,000
Inventory 2,026,000
Other Current Assets 1,430,000
Total Current Assets  (as reported)12,317,000
Total Current Assets  (calculated)12,317,000
+/-0
Long-term Assets
Property Plant Equipment 5,346,000
Goodwill 8,314,000
Intangible Assets 22,832,000
Long-term Assets Other 4,060,000
Long-term Assets  (as reported)41,262,000
Long-term Assets  (calculated)40,552,000
+/- 710,000

Liabilities & Shareholders' Equity

Total Current Liabilities10,781,000
Long-term Liabilities24,603,000
Total Stockholder Equity18,281,000
Total Current Liabilities
Short-term Debt 1,810,000
Short Long Term Debt 1,810,000
Accounts payable 537,000
Other Current Liabilities 7,696,000
Total Current Liabilities  (as reported)10,781,000
Total Current Liabilities  (calculated)11,853,000
+/- 1,072,000
Long-term Liabilities
Long term Debt 21,540,000
Long-term Liabilities Other 1,417,000
Long-term Liabilities  (as reported)24,603,000
Long-term Liabilities  (calculated)22,957,000
+/- 1,646,000
Total Stockholder Equity
Common Stock1,000
Retained Earnings 11,165,000
Accumulated Other Comprehensive Income 93,000
Other Stockholders Equity 7,022,000
Total Stockholder Equity (as reported)18,281,000
Total Stockholder Equity (calculated)18,281,000
+/-0
Other
Capital Stock1,000
Cash and Short Term Investments 4,198,000
Common Stock Shares Outstanding 1,251,000
Current Deferred Revenue738,000
Liabilities and Stockholders Equity 53,581,000
Net Debt 20,578,000
Net Invested Capital 41,631,000
Net Working Capital 1,537,000
Short Long Term Debt Total 23,350,000



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-30
> Total Assets 
0
0
0
12,500
0
0
0
108,700
106,600
107,100
144,800
146,800
141,600
139,800
133,900
126,600
123,600
119,200
111,100
102,400
93,800
176,000
315,400
304,000
315,400
310,700
312,400
354,000
348,200
352,100
349,400
333,300
316,700
302,900
288,600
272,100
449,200
436,800
434,322
436,537
435,915
678,099
657,545
636,662
632,935
794,786
787,737
815,972
876,227
1,288,183
942,770
1,074,862
1,168,141
1,554,722
1,675,522
1,808,467
1,985,676
2,155,963
2,369,483
2,688,114
2,918,685
3,764,651
4,036,534
5,179,648
5,299,132
4,085,981
4,615,379
4,825,780
5,317,575
5,834,716
5,879,003
6,517,417
6,974,128
7,018,574
7,519,914
8,387,092
8,936,980
9,698,559
10,695,998
10,496,708
11,455,591
11,592,630
12,987,354
12,694,140
12,639,898
17,303,134
19,950,386
20,501,950
20,963,829
21,239,838
22,211,668
22,624,374
22,468,428
22,496,785
28,077,692
31,206,164
28,844,393
34,664,000
38,321,000
39,167,000
50,637,000
51,839,000
47,765,000
49,980,000
56,609,000
56,977,000
57,701,000
60,263,000
64,662,000
70,283,000
65,381,000
65,355,000
64,305,000
63,675,000
62,837,000
63,210,000
59,146,000
61,627,000
59,741,000
55,934,000
60,878,000
68,407,000
67,492,000
67,984,000
67,098,000
67,952,000
63,080,000
62,870,000
62,557,000
63,171,000
61,876,000
62,337,000
62,373,000
62,125,000
56,292,000
53,579,000
53,579,00056,292,00062,125,00062,373,00062,337,00061,876,00063,171,00062,557,00062,870,00063,080,00067,952,00067,098,00067,984,00067,492,00068,407,00060,878,00055,934,00059,741,00061,627,00059,146,00063,210,00062,837,00063,675,00064,305,00065,355,00065,381,00070,283,00064,662,00060,263,00057,701,00056,977,00056,609,00049,980,00047,765,00051,839,00050,637,00039,167,00038,321,00034,664,00028,844,39331,206,16428,077,69222,496,78522,468,42822,624,37422,211,66821,239,83820,963,82920,501,95019,950,38617,303,13412,639,89812,694,14012,987,35411,592,63011,455,59110,496,70810,695,9989,698,5598,936,9808,387,0927,519,9147,018,5746,974,1286,517,4175,879,0035,834,7165,317,5754,825,7804,615,3794,085,9815,299,1325,179,6484,036,5343,764,6512,918,6852,688,1142,369,4832,155,9631,985,6761,808,4671,675,5221,554,7221,168,1411,074,862942,7701,288,183876,227815,972787,737794,786632,935636,662657,545678,099435,915436,537434,322436,800449,200272,100288,600302,900316,700333,300349,400352,100348,200354,000312,400310,700315,400304,000315,400176,00093,800102,400111,100119,200123,600126,600133,900139,800141,600146,800144,800107,100106,600108,70000012,500000
   > Total Current Assets 
0
0
0
10,400
0
0
0
106,200
103,800
104,200
141,200
140,200
133,400
130,200
124,100
116,900
114,000
107,900
98,900
91,100
83,300
166,000
306,300
295,200
306,600
300,300
300,700
342,000
336,500
340,300
337,400
321,800
305,600
288,300
272,000
255,400
387,700
372,000
367,606
371,447
369,840
593,798
570,378
546,191
544,607
707,759
700,644
726,323
788,135
1,183,760
832,453
963,771
926,997
1,265,898
1,395,014
1,531,776
1,707,368
1,849,694
2,070,244
2,384,820
2,297,715
3,092,208
3,375,405
2,491,869
4,032,400
2,429,206
2,440,559
2,447,174
2,545,043
3,028,292
2,948,257
3,669,377
4,326,683
4,300,281
4,615,915
5,111,316
5,649,122
4,812,558
7,335,192
7,057,041
7,995,475
5,708,082
9,461,967
8,759,572
8,686,959
13,918,785
5,081,802
5,577,893
6,034,548
6,078,456
6,375,837
6,806,858
6,673,531
6,726,664
12,235,324
15,086,847
12,451,677
17,747,000
21,257,000
22,037,000
33,207,000
34,017,000
29,365,000
32,230,000
38,586,000
38,481,000
39,525,000
42,462,000
46,626,000
41,346,000
36,762,000
36,056,000
35,125,000
35,653,000
34,306,000
34,514,000
29,248,000
31,489,000
30,242,000
26,351,000
31,915,000
15,816,000
13,166,000
14,498,000
14,200,000
15,056,000
13,214,000
13,175,000
13,898,000
15,227,000
14,372,000
15,411,000
16,013,000
16,454,000
14,041,000
12,317,000
12,317,00014,041,00016,454,00016,013,00015,411,00014,372,00015,227,00013,898,00013,175,00013,214,00015,056,00014,200,00014,498,00013,166,00015,816,00031,915,00026,351,00030,242,00031,489,00029,248,00034,514,00034,306,00035,653,00035,125,00036,056,00036,762,00041,346,00046,626,00042,462,00039,525,00038,481,00038,586,00032,230,00029,365,00034,017,00033,207,00022,037,00021,257,00017,747,00012,451,67715,086,84712,235,3246,726,6646,673,5316,806,8586,375,8376,078,4566,034,5485,577,8935,081,80213,918,7858,686,9598,759,5729,461,9675,708,0827,995,4757,057,0417,335,1924,812,5585,649,1225,111,3164,615,9154,300,2814,326,6833,669,3772,948,2573,028,2922,545,0432,447,1742,440,5592,429,2064,032,4002,491,8693,375,4053,092,2082,297,7152,384,8202,070,2441,849,6941,707,3681,531,7761,395,0141,265,898926,997963,771832,4531,183,760788,135726,323700,644707,759544,607546,191570,378593,798369,840371,447367,606372,000387,700255,400272,000288,300305,600321,800337,400340,300336,500342,000300,700300,300306,600295,200306,300166,00083,30091,10098,900107,900114,000116,900124,100130,200133,400140,200141,200104,200103,800106,20000010,400000
       Cash And Cash Equivalents 
0
0
0
10,300
0
0
0
87,900
17,900
2,300
47,800
2,100
3,500
2,100
8,600
13,000
43,700
26,600
15,300
30,400
8,500
72,400
49,400
182,900
156,000
132,000
104,700
139,000
45,700
32,000
34,300
37,000
43,200
32,500
58,400
45,300
70,800
47,000
37,296
42,740
43,374
197,292
77,403
46,921
37,346
162,339
115,086
122,006
121,608
616,931
117,477
169,355
103,317
194,719
155,585
226,563
301,450
280,909
281,941
793,618
592,722
707,913
268,677
884,449
559,580
816,007
729,142
701,648
584,128
968,086
722,884
1,119,599
1,209,424
1,459,302
1,663,646
1,040,874
1,024,599
1,272,958
936,880
1,482,639
1,022,993
907,879
1,835,978
905,779
909,359
9,883,777
1,451,942
1,625,500
1,550,710
1,803,694
1,863,972
2,202,176
2,010,736
2,112,806
6,404,153
8,730,522
6,209,060
10,027,000
10,635,000
7,417,000
13,965,000
12,851,000
6,315,000
6,485,000
9,809,000
8,229,000
10,285,000
8,712,000
11,508,000
7,588,000
7,643,000
13,234,000
14,569,000
17,940,000
16,927,000
11,240,000
9,474,000
11,631,000
10,051,000
6,746,000
12,886,000
5,997,000
4,065,000
4,893,000
4,362,000
5,338,000
4,296,000
4,739,000
4,699,000
5,412,000
4,936,000
5,704,000
5,705,000
6,085,000
4,718,000
2,772,000
2,772,0004,718,0006,085,0005,705,0005,704,0004,936,0005,412,0004,699,0004,739,0004,296,0005,338,0004,362,0004,893,0004,065,0005,997,00012,886,0006,746,00010,051,00011,631,0009,474,00011,240,00016,927,00017,940,00014,569,00013,234,0007,643,0007,588,00011,508,0008,712,00010,285,0008,229,0009,809,0006,485,0006,315,00012,851,00013,965,0007,417,00010,635,00010,027,0006,209,0608,730,5226,404,1532,112,8062,010,7362,202,1761,863,9721,803,6941,550,7101,625,5001,451,9429,883,777909,359905,7791,835,978907,8791,022,9931,482,639936,8801,272,9581,024,5991,040,8741,663,6461,459,3021,209,4241,119,599722,884968,086584,128701,648729,142816,007559,580884,449268,677707,913592,722793,618281,941280,909301,450226,563155,585194,719103,317169,355117,477616,931121,608122,006115,086162,33937,34646,92177,403197,29243,37442,74037,29647,00070,80045,30058,40032,50043,20037,00034,30032,00045,700139,000104,700132,000156,000182,90049,40072,4008,50030,40015,30026,60043,70013,0008,6002,1003,5002,10047,8002,30017,90087,90000010,300000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
236,600
247,400
254,496
252,807
249,825
315,586
406,407
409,101
403,208
420,512
449,583
437,482
503,183
325,443
494,666
512,088
517,544
512,281
682,057
749,025
846,971
973,129
1,189,826
995,656
1,067,554
1,615,972
2,270,944
603,134
2,294,368
120,844
196,594
174,776
182,637
203,892
191,311
228,122
709,870
330,760
396,648
203,394
330,713
384,017
715,308
518,286
1,284,538
1,190,789
1,175,321
1,364,539
1,347,776
16,491
0
82,044
144,775
58,556
78,804
85,194
79,758
18,756
64,877
68,546
107,266
101,000
659,000
1,194,000
1,749,000
1,756,000
2,004,000
2,267,000
2,457,000
3,666,000
3,830,000
12,384,000
16,879,000
17,922,000
16,355,000
12,683,000
13,897,000
12,149,000
10,977,000
15,943,000
13,382,000
12,721,000
10,734,000
12,168,000
11,089,000
1,411,000
1,601,000
1,632,000
1,376,000
1,182,000
1,029,000
924,000
961,000
973,000
936,000
8,001,000
1,159,000
1,179,000
1,341,000
1,426,000
1,426,0001,341,0001,179,0001,159,0008,001,000936,000973,000961,000924,0001,029,0001,182,0001,376,0001,632,0001,601,0001,411,00011,089,00012,168,00010,734,00012,721,00013,382,00015,943,00010,977,00012,149,00013,897,00012,683,00016,355,00017,922,00016,879,00012,384,0003,830,0003,666,0002,457,0002,267,0002,004,0001,756,0001,749,0001,194,000659,000101,000107,26668,54664,87718,75679,75885,19478,80458,556144,77582,044016,4911,347,7761,364,5391,175,3211,190,7891,284,538518,286715,308384,017330,713203,394396,648330,760709,870228,122191,311203,892182,637174,776196,594120,8442,294,368603,1342,270,9441,615,9721,067,554995,6561,189,826973,129846,971749,025682,057512,281517,544512,088494,666325,443503,183437,482449,583420,512403,208409,101406,407315,586249,825252,807254,496247,400236,600000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
137,200
0
0
0
0
0
0
0
0
0
0
0
1,500
3,000
0
0
0
0
0
0
0
0
0
0
0
46,700
45,600
46,666
46,644
46,084
48,814
51,187
54,354
59,402
74,228
76,935
101,462
114,062
175,036
145,980
200,306
201,056
235,217
257,491
277,305
304,298
371,245
385,444
371,984
400,623
396,125
433,633
489,319
585,050
609,320
692,066
734,512
803,628
795,127
979,802
1,021,369
1,047,205
1,023,397
1,068,000
1,242,899
1,339,165
1,389,534
1,491,332
1,482,900
1,670,405
1,621,966
1,801,212
1,938,645
1,867,092
1,951,167
2,163,659
1,702,818
1,766,091
1,751,388
1,945,189
1,895,913
1,971,926
2,100,286
3,236,195
3,436,711
2,850,367
4,635,000
4,835,000
5,331,000
6,105,000
5,854,000
6,163,000
5,752,000
5,075,000
4,514,000
4,034,000
4,478,000
4,122,000
3,851,000
3,775,000
3,541,000
3,465,000
3,327,000
3,283,000
3,396,000
3,315,000
3,582,000
3,907,000
3,194,000
3,913,000
4,892,000
3,925,000
4,149,000
4,566,000
4,493,000
3,787,000
4,118,000
4,354,000
4,777,000
4,162,000
4,229,000
4,790,000
4,660,000
4,669,000
4,663,000
4,663,0004,669,0004,660,0004,790,0004,229,0004,162,0004,777,0004,354,0004,118,0003,787,0004,493,0004,566,0004,149,0003,925,0004,892,0003,913,0003,194,0003,907,0003,582,0003,315,0003,396,0003,283,0003,327,0003,465,0003,541,0003,775,0003,851,0004,122,0004,478,0004,034,0004,514,0005,075,0005,752,0006,163,0005,854,0006,105,0005,331,0004,835,0004,635,0002,850,3673,436,7113,236,1952,100,2861,971,9261,895,9131,945,1891,751,3881,766,0911,702,8182,163,6591,951,1671,867,0921,938,6451,801,2121,621,9661,670,4051,482,9001,491,3321,389,5341,339,1651,242,8991,068,0001,023,3971,047,2051,021,369979,802795,127803,628734,512692,066609,320585,050489,319433,633396,125400,623371,984385,444371,245304,298277,305257,491235,217201,056200,306145,980175,036114,062101,46276,93574,22859,40254,35451,18748,81446,08446,64446,66645,60046,700000000000003,0001,50000000000000137,20000000000000
       Other Current Assets 
0
0
0
100
0
0
0
18,300
85,900
101,900
93,400
900
129,900
128,100
115,500
103,900
70,300
81,300
83,600
60,700
74,800
93,600
256,900
110,800
147,600
168,300
196,000
203,000
290,800
308,300
303,100
284,800
262,400
255,800
213,600
210,100
13,500
11,000
8,162
8,964
11,330
11,544
14,844
12,095
13,444
11,400
12,844
22,696
11,113
14,722
17,810
18,488
23,725
225,579
198,629
172,920
1
88,420
77,527
57,502
15,430
22,073
40,769
56,771
62,138
22,863
32,121
40,118
31,602
35,242
105,439
115,194
140,791
126,066
164,929
2,898,446
3,292,130
66,891
4,619,915
4,217,535
5,051,681
116,244
6,356,298
5,499,312
5,482,116
126,846
1,500,110
2,271,674
2,651,088
797,727
217,748
176,355
109,195
91,925
201,011
199,360
267,247
472,000
761,000
553,000
2,103,000
506,000
259,000
517,000
820,000
1,062,000
1,801,000
1,610,000
1,664,000
1,661,000
1,600,000
2,411,000
2,171,000
1,606,000
1,939,000
2,264,000
1,308,000
1,440,000
1,272,000
1,483,000
2,030,000
2,013,000
1,908,000
1,479,000
2,011,000
2,141,000
2,035,000
1,900,000
2,077,000
1,774,000
1,846,000
1,758,000
2,663,000
2,374,000
1,460,000
1,430,000
1,430,0001,460,0002,374,0002,663,0001,758,0001,846,0001,774,0002,077,0001,900,0002,035,0002,141,0002,011,0001,479,0001,908,0002,013,0002,030,0001,483,0001,272,0001,440,0001,308,0002,264,0001,939,0001,606,0002,171,0002,411,0001,600,0001,661,0001,664,0001,610,0001,801,0001,062,000820,000517,000259,000506,0002,103,000553,000761,000472,000267,247199,360201,01191,925109,195176,355217,748797,7272,651,0882,271,6741,500,110126,8465,482,1165,499,3126,356,298116,2445,051,6814,217,5354,619,91566,8913,292,1302,898,446164,929126,066140,791115,194105,43935,24231,60240,11832,12122,86362,13856,77140,76922,07315,43057,50277,52788,4201172,920198,629225,57923,72518,48817,81014,72211,11322,69612,84411,40013,44412,09514,84411,54411,3308,9648,16211,00013,500210,100213,600255,800262,400284,800303,100308,300290,800203,000196,000168,300147,600110,800256,90093,60074,80060,70083,60081,30070,300103,900115,500128,100129,90090093,400101,90085,90018,300000100000
   > Long-term Assets 
0
0
0
2,100
0
0
0
2,500
2,800
2,900
3,600
6,600
8,200
9,600
9,800
9,700
9,600
11,300
12,200
11,300
10,500
10,000
9,100
8,800
8,800
10,400
11,700
12,000
11,700
11,800
12,000
11,500
11,100
14,600
16,600
16,700
61,500
64,800
66,716
65,090
66,075
84,301
87,167
90,471
88,328
87,027
87,093
89,649
88,092
104,423
110,317
111,091
241,144
288,824
280,508
276,691
278,308
306,269
299,239
303,294
620,970
672,443
661,129
2,687,779
1,266,732
1,656,775
2,174,820
2,378,606
2,772,532
2,806,424
2,930,746
2,848,040
2,647,445
2,718,293
2,903,999
3,275,776
3,287,858
4,886,001
3,360,806
3,439,667
3,460,116
5,884,548
3,525,387
3,934,568
3,952,939
3,384,349
14,868,584
14,924,057
14,929,281
15,161,382
15,835,831
15,817,516
15,794,897
15,770,121
15,842,368
16,119,317
16,392,716
16,917,000
17,064,000
17,130,000
17,430,000
17,822,000
18,400,000
17,750,000
18,023,000
18,496,000
18,176,000
17,801,000
18,036,000
28,937,000
28,619,000
29,299,000
29,180,000
28,022,000
28,531,000
28,696,000
29,898,000
30,138,000
29,499,000
29,583,000
28,963,000
52,591,000
54,326,000
53,486,000
52,898,000
52,896,000
49,866,000
49,694,000
48,659,000
47,944,000
47,505,000
46,926,000
46,361,000
45,671,000
42,251,000
41,262,000
41,262,00042,251,00045,671,00046,361,00046,926,00047,505,00047,944,00048,659,00049,694,00049,866,00052,896,00052,898,00053,486,00054,326,00052,591,00028,963,00029,583,00029,499,00030,138,00029,898,00028,696,00028,531,00028,022,00029,180,00029,299,00028,619,00028,937,00018,036,00017,801,00018,176,00018,496,00018,023,00017,750,00018,400,00017,822,00017,430,00017,130,00017,064,00016,917,00016,392,71616,119,31715,842,36815,770,12115,794,89715,817,51615,835,83115,161,38214,929,28114,924,05714,868,5843,384,3493,952,9393,934,5683,525,3875,884,5483,460,1163,439,6673,360,8064,886,0013,287,8583,275,7762,903,9992,718,2932,647,4452,848,0402,930,7462,806,4242,772,5322,378,6062,174,8201,656,7751,266,7322,687,779661,129672,443620,970303,294299,239306,269278,308276,691280,508288,824241,144111,091110,317104,42388,09289,64987,09387,02788,32890,47187,16784,30166,07565,09066,71664,80061,50016,70016,60014,60011,10011,50012,00011,80011,70012,00011,70010,4008,8008,8009,10010,00010,50011,30012,20011,3009,6009,7009,8009,6008,2006,6003,6002,9002,8002,5000002,100000
       Property Plant Equipment 
0
0
0
1,900
0
0
0
2,200
2,500
2,500
3,200
6,300
7,600
8,900
9,000
8,900
8,600
10,300
11,100
10,400
9,600
9,000
7,900
7,800
7,600
9,200
10,300
10,500
10,200
10,300
10,500
10,100
9,700
10,200
12,100
12,500
49,200
51,400
52,224
51,771
54,093
55,174
54,975
60,141
62,925
62,828
62,851
64,671
65,709
67,727
69,529
70,760
199,550
198,200
198,951
206,789
211,809
223,106
225,428
237,221
238,310
242,568
240,587
253,760
288,105
361,299
377,067
391,016
441,797
447,696
455,759
493,012
512,281
528,799
679,437
697,426
701,371
699,970
695,601
695,043
692,032
701,235
703,794
721,884
761,190
774,406
782,867
811,799
856,184
1,100,259
1,125,794
1,135,993
1,133,032
1,166,181
1,303,029
1,380,776
1,509,796
1,674,000
1,765,000
1,899,000
2,143,000
2,276,000
2,431,000
2,599,000
2,714,000
2,865,000
2,922,000
3,012,000
3,100,000
3,295,000
3,415,000
3,659,000
3,791,000
4,006,000
4,116,000
4,249,000
4,377,000
4,502,000
4,564,000
4,653,000
4,810,000
4,967,000
4,990,000
4,996,000
5,037,000
5,121,000
5,253,000
5,299,000
5,349,000
5,475,000
5,479,000
5,540,000
5,572,000
5,317,000
5,321,000
5,346,000
5,346,0005,321,0005,317,0005,572,0005,540,0005,479,0005,475,0005,349,0005,299,0005,253,0005,121,0005,037,0004,996,0004,990,0004,967,0004,810,0004,653,0004,564,0004,502,0004,377,0004,249,0004,116,0004,006,0003,791,0003,659,0003,415,0003,295,0003,100,0003,012,0002,922,0002,865,0002,714,0002,599,0002,431,0002,276,0002,143,0001,899,0001,765,0001,674,0001,509,7961,380,7761,303,0291,166,1811,133,0321,135,9931,125,7941,100,259856,184811,799782,867774,406761,190721,884703,794701,235692,032695,043695,601699,970701,371697,426679,437528,799512,281493,012455,759447,696441,797391,016377,067361,299288,105253,760240,587242,568238,310237,221225,428223,106211,809206,789198,951198,200199,55070,76069,52967,72765,70964,67162,85162,82862,92560,14154,97555,17454,09351,77152,22451,40049,20012,50012,10010,2009,70010,10010,50010,30010,20010,50010,3009,2007,6007,8007,9009,0009,60010,40011,10010,3008,6008,9009,0008,9007,6006,3003,2002,5002,5002,2000001,900000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131,409
130,188
129,898
0
0
0
0
0
0
0
0
1,524,777
462,558
462,558
532,669
1,425,592
1,629,971
1,004,102
1,004,102
1,004,102
1,078,919
1,078,919
1,078,919
1,060,919
1,188,157
1,188,157
1,188,157
1,169,023
1,171,561
1,171,561
1,171,561
1,172,000
1,172,000
1,172,000
1,172,000
1,172,000
1,172,000
1,172,000
1,172,000
1,172,000
1,172,000
1,172,000
1,172,000
4,159,000
4,159,000
4,124,000
4,117,000
4,117,000
4,117,000
4,117,000
4,117,000
4,117,000
4,117,000
4,117,000
4,117,000
8,108,000
8,334,000
8,334,000
8,332,000
8,332,000
8,314,000
8,314,000
8,314,000
8,314,000
8,314,000
8,314,000
8,314,000
8,314,000
8,314,000
8,314,000
8,314,0008,314,0008,314,0008,314,0008,314,0008,314,0008,314,0008,314,0008,314,0008,314,0008,332,0008,332,0008,334,0008,334,0008,108,0004,117,0004,117,0004,117,0004,117,0004,117,0004,117,0004,117,0004,117,0004,117,0004,124,0004,159,0004,159,0001,172,0001,172,0001,172,0001,172,0001,172,0001,172,0001,172,0001,172,0001,172,0001,172,0001,172,0001,172,0001,171,5611,171,5611,171,5611,169,0231,188,1571,188,1571,188,1571,060,9191,078,9191,078,9191,078,9191,004,1021,004,1021,004,1021,629,9711,425,592532,669462,558462,5581,524,77700000000129,898130,188131,409000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,654,178
1,936,818
2,247,871
2,967,727
2,216,610
2,744,150
3,219,403
3,344,999
3,228,994
3,224,981
63,704
48,168
564,130
955,603
719,836
688,254
688,428
665,063
439,028
389,871
782,315
1,375,400
1,598,000
3,220,000
6,056,000
9,400,000
11,601,000
13,003,000
15,864,000
19,345,000
20,485,000
19,902,000
15,480,000
12,973,000
11,184,000
8,104,000
5,739,000
2,378,000
1,423,000
2,221,000
3,051,000
2,195,000
1,488,000
3,529,000
2,276,000
2,074,000
502,000
579,000
836,000
1,099,000
1,309,000
1,427,000
1,337,000
1,282,000
1,245,000
1,327,000
1,334,000
1,156,000
1,163,000
0
0
001,163,0001,156,0001,334,0001,327,0001,245,0001,282,0001,337,0001,427,0001,309,0001,099,000836,000579,000502,0002,074,0002,276,0003,529,0001,488,0002,195,0003,051,0002,221,0001,423,0002,378,0005,739,0008,104,00011,184,00012,973,00015,480,00019,902,00020,485,00019,345,00015,864,00013,003,00011,601,0009,400,0006,056,0003,220,0001,598,0001,375,400782,315389,871439,028665,063688,428688,254719,836955,603564,13048,16863,7043,224,9813,228,9943,344,9993,219,4032,744,1502,216,6102,967,7272,247,8711,936,8181,654,178000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131,409
130,188
129,898
0
0
0
0
0
0
1,570,790
1,555,602
1,524,777
1,047,236
1,032,255
1,043,904
1,425,592
1,629,971
2,128,410
2,111,003
1,062,864
11,767,027
11,751,191
11,735,354
11,736,393
12,077,548
12,056,002
12,034,457
11,900,106
11,707,830
11,508,319
11,306,547
11,073,000
10,867,000
10,660,000
10,454,000
10,247,000
9,923,000
9,713,000
9,386,000
8,971,000
8,761,000
8,551,000
8,342,000
17,100,000
16,803,000
16,496,000
16,314,000
15,738,000
15,438,000
15,152,000
14,864,000
13,786,000
13,502,000
13,225,000
12,939,000
33,126,000
34,781,000
34,341,000
33,900,000
33,455,000
30,331,000
29,884,000
29,440,000
28,894,000
28,348,000
27,750,000
27,152,000
26,454,000
23,428,000
22,832,000
22,832,00023,428,00026,454,00027,152,00027,750,00028,348,00028,894,00029,440,00029,884,00030,331,00033,455,00033,900,00034,341,00034,781,00033,126,00012,939,00013,225,00013,502,00013,786,00014,864,00015,152,00015,438,00015,738,00016,314,00016,496,00016,803,00017,100,0008,342,0008,551,0008,761,0008,971,0009,386,0009,713,0009,923,00010,247,00010,454,00010,660,00010,867,00011,073,00011,306,54711,508,31911,707,83011,900,10612,034,45712,056,00212,077,54811,736,39311,735,35411,751,19111,767,0271,062,8642,111,0032,128,4101,629,9711,425,5921,043,9041,032,2551,047,2361,524,7771,555,6021,570,790000000129,898130,188131,409000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,492
13,319
11,982
29,127
32,192
30,330
25,403
24,199
24,242
24,978
22,383
36,696
40,788
40,331
41,594
90,624
81,557
69,902
66,500
83,163
73,811
66,073
382,660
429,875
420,542
2,434,019
978,627
1,295,476
1,797,753
1,987,590
2,330,735
2,358,728
2,474,987
2,355,028
2,135,164
2,189,494
2,224,562
3,688,359
3,937,999
4,186,031
4,876,169
4,092,651
4,731,612
5,183,313
5,432,428
5,753,211
5,731,441
2,609,943
13,340,987
13,846,049
14,227,266
13,983,232
14,422,777
14,415,852
14,367,335
14,056,851
13,804,034
14,326,049
14,772,566
15,276,000
16,494,000
19,175,000
22,584,000
24,800,000
26,067,000
29,028,000
32,470,000
33,667,000
33,355,000
28,659,000
26,245,000
35,165,000
2,517,000
2,481,000
-1,000
2,555,000
2,466,000
2,244,000
2,327,000
3,119,000
3,607,000
3,498,000
3,818,000
4,799,000
6,221,000
53,486,000
5,629,000
5,988,000
1,000
1,000
5,556,000
1,000
-1,000
5,322,000
-1,000
5,586,000
6,479,000
0
06,479,0005,586,000-1,0005,322,000-1,0001,0005,556,0001,0001,0005,988,0005,629,00053,486,0006,221,0004,799,0003,818,0003,498,0003,607,0003,119,0002,327,0002,244,0002,466,0002,555,000-1,0002,481,0002,517,00035,165,00026,245,00028,659,00033,355,00033,667,00032,470,00029,028,00026,067,00024,800,00022,584,00019,175,00016,494,00015,276,00014,772,56614,326,04913,804,03414,056,85114,367,33514,415,85214,422,77713,983,23214,227,26613,846,04913,340,9872,609,9435,731,4415,753,2115,432,4285,183,3134,731,6124,092,6514,876,1694,186,0313,937,9993,688,3592,224,5622,189,4942,135,1642,355,0282,474,9872,358,7282,330,7351,987,5901,797,7531,295,476978,6272,434,019420,542429,875382,66066,07373,81183,16366,50069,90281,55790,62441,59440,33140,78836,69622,38324,97824,24224,19925,40330,33032,19229,12711,98213,31914,49200000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
132,609
134,417
101,498
81,933
78,040
95,291
153,379
134,865
87,168
82,728
144,015
107,729
116,263
110,331
131,107
139,663
155,667
162,738
154,765
138,966
153,552
163,720
236,000
205,000
177,000
291,000
324,000
292,000
433,000
481,000
402,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000402,000481,000433,000292,000324,000291,000177,000205,000236,000163,720153,552138,966154,765162,738155,667139,663131,107110,331116,263107,729144,01582,72887,168134,865153,37995,29178,04081,933101,498134,417132,609000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
2,300
0
0
0
3,100
2,600
5,500
6,100
7,400
6,400
10,200
10,500
11,300
14,900
17,200
16,600
16,300
14,300
15,200
17,700
16,700
17,500
19,000
27,100
23,400
22,400
34,800
38,000
32,800
32,000
32,400
29,700
27,200
149,400
139,500
133,279
134,330
59,815
326,975
323,205
322,247
334,796
342,349
330,793
339,936
353,398
716,842
741,588
747,856
749,809
551,748
543,425
541,304
590,404
285,091
306,016
296,083
301,820
728,713
638,072
1,981,734
2,000,302
2,217,172
2,174,811
2,225,037
2,174,130
2,234,427
2,439,510
2,652,097
2,680,582
2,673,077
2,502,631
3,073,123
3,184,823
3,193,401
3,193,326
3,796,708
5,576,819
5,470,793
6,811,993
6,482,809
6,406,692
10,435,785
12,586,302
12,418,563
12,213,667
11,688,969
11,819,195
11,280,990
11,275,955
10,752,284
14,375,498
14,776,822
14,980,783
18,845,000
20,733,000
22,533,000
32,693,000
32,726,000
33,746,000
33,865,000
39,249,000
37,614,000
36,784,000
37,172,000
39,408,000
49,782,000
44,730,000
43,621,000
41,298,000
42,141,000
40,746,000
40,459,000
38,410,000
38,977,000
37,562,000
37,792,000
43,407,000
50,186,000
48,528,000
48,274,000
45,627,000
46,888,000
43,165,000
42,655,000
41,500,000
41,962,000
40,937,000
41,243,000
40,131,000
39,376,000
38,837,000
35,384,000
35,384,00038,837,00039,376,00040,131,00041,243,00040,937,00041,962,00041,500,00042,655,00043,165,00046,888,00045,627,00048,274,00048,528,00050,186,00043,407,00037,792,00037,562,00038,977,00038,410,00040,459,00040,746,00042,141,00041,298,00043,621,00044,730,00049,782,00039,408,00037,172,00036,784,00037,614,00039,249,00033,865,00033,746,00032,726,00032,693,00022,533,00020,733,00018,845,00014,980,78314,776,82214,375,49810,752,28411,275,95511,280,99011,819,19511,688,96912,213,66712,418,56312,586,30210,435,7856,406,6926,482,8096,811,9935,470,7935,576,8193,796,7083,193,3263,193,4013,184,8233,073,1232,502,6312,673,0772,680,5822,652,0972,439,5102,234,4272,174,1302,225,0372,174,8112,217,1722,000,3021,981,734638,072728,713301,820296,083306,016285,091590,404541,304543,425551,748749,809747,856741,588716,842353,398339,936330,793342,349334,796322,247323,205326,97559,815134,330133,279139,500149,40027,20029,70032,40032,00032,80038,00034,80022,40023,40027,10019,00017,50016,70017,70015,20014,30016,30016,60017,20014,90011,30010,50010,2006,4007,4006,1005,5002,6003,1000002,300000
   > Total Current Liabilities 
0
0
0
1,800
0
0
0
2,400
1,800
4,500
5,000
6,300
5,000
8,200
7,800
8,800
8,000
10,700
10,400
10,900
9,600
11,000
15,000
14,600
16,100
16,100
24,900
21,500
20,800
33,400
36,900
31,900
31,300
31,800
29,300
27,000
56,800
47,900
42,673
44,630
50,632
58,238
55,202
56,690
71,744
80,117
69,082
82,692
85,476
104,892
130,012
136,589
133,402
185,895
175,789
174,829
217,526
253,454
270,219
261,190
267,866
455,338
421,903
507,968
581,829
764,276
710,486
751,725
691,439
736,275
939,005
2,451,334
1,259,134
1,220,992
1,261,797
1,777,882
1,889,249
1,871,631
1,887,651
3,105,723
2,590,108
2,464,950
2,768,765
2,310,841
2,224,431
2,514,790
4,187,904
4,986,674
4,802,148
4,270,020
4,290,215
4,937,138
4,895,124
6,325,528
5,914,776
6,227,997
6,054,952
5,618,000
7,428,000
8,925,000
9,360,000
9,891,000
10,910,000
10,444,000
11,073,000
9,219,000
8,282,000
8,492,000
9,597,000
11,635,000
10,670,000
10,912,000
10,116,000
10,605,000
9,397,000
8,961,000
9,567,000
9,759,000
8,879,000
10,564,000
9,509,000
11,397,000
9,705,000
10,214,000
10,245,000
11,610,000
8,558,000
9,220,000
10,423,000
11,237,000
10,528,000
13,964,000
11,945,000
11,280,000
13,015,000
10,781,000
10,781,00013,015,00011,280,00011,945,00013,964,00010,528,00011,237,00010,423,0009,220,0008,558,00011,610,00010,245,00010,214,0009,705,00011,397,0009,509,00010,564,0008,879,0009,759,0009,567,0008,961,0009,397,00010,605,00010,116,00010,912,00010,670,00011,635,0009,597,0008,492,0008,282,0009,219,00011,073,00010,444,00010,910,0009,891,0009,360,0008,925,0007,428,0005,618,0006,054,9526,227,9975,914,7766,325,5284,895,1244,937,1384,290,2154,270,0204,802,1484,986,6744,187,9042,514,7902,224,4312,310,8412,768,7652,464,9502,590,1083,105,7231,887,6511,871,6311,889,2491,777,8821,261,7971,220,9921,259,1342,451,334939,005736,275691,439751,725710,486764,276581,829507,968421,903455,338267,866261,190270,219253,454217,526174,829175,789185,895133,402136,589130,012104,89285,47682,69269,08280,11771,74456,69055,20258,23850,63244,63042,67347,90056,80027,00029,30031,80031,30031,90036,90033,40020,80021,50024,90016,10016,10014,60015,00011,0009,60010,90010,40010,7008,0008,8007,8008,2005,0006,3005,0004,5001,8002,4000001,800000
       Short-term Debt 
0
0
0
300
0
0
0
300
400
500
500
600
700
900
1,100
1,100
2,900
2,900
3,000
3,000
3,000
3,000
2,900
2,900
2,900
3,600
3,500
3,100
2,400
1,900
1,400
900
800
800
800
800
3,600
3,200
3,017
2,889
2,876
3,034
2,854
2,609
2,467
1,492
1,098
687
263
194
149
89
77
139
120,783
115,885
0
181
161
141
118
60,206
60,374
60,249
60,115
18,747
307
305
245
286
216
1,303,662
6,055
5,631
5,613
405,622
205,613
5,587
7,088
1,124,230
632,386
646,345
653,093
7,345
1,587
1,572
1,351,573
1,972,816
1,730,895
1,169,490
942,811
1,488,225
1,457,379
63,831
45,767
35,875
27,382
15,000
11,000
7,000
4,000
2,000
1,745,000
700,000
700,000
1,408,000
1,189,000
26,296,000
1,747,000
2,747,000
2,497,000
2,998,000
2,747,000
2,748,000
2,498,000
1,999,000
2,498,000
2,499,000
1,999,000
2,999,000
1,498,000
2,757,000
2,259,000
2,261,000
2,511,000
1,516,000
1,025,000
1,021,000
2,270,000
2,273,000
2,283,000
4,037,000
1,793,000
1,798,000
3,667,000
1,810,000
1,810,0003,667,0001,798,0001,793,0004,037,0002,283,0002,273,0002,270,0001,021,0001,025,0001,516,0002,511,0002,261,0002,259,0002,757,0001,498,0002,999,0001,999,0002,499,0002,498,0001,999,0002,498,0002,748,0002,747,0002,998,0002,497,0002,747,0001,747,00026,296,0001,189,0001,408,000700,000700,0001,745,0002,0004,0007,00011,00015,00027,38235,87545,76763,8311,457,3791,488,225942,8111,169,4901,730,8951,972,8161,351,5731,5721,5877,345653,093646,345632,3861,124,2307,0885,587205,613405,6225,6135,6316,0551,303,66221628624530530718,74760,11560,24960,37460,2061181411611810115,885120,78313977891491942636871,0981,4922,4672,6092,8543,0342,8762,8893,0173,2003,6008008008008009001,4001,9002,4003,1003,5003,6002,9002,9002,9003,0003,0003,0003,0002,9002,9001,1001,100900700600500500400300000300000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483,000
0
0
0
982,000
1,745,000
700,000
700,000
26,346,000
15,938
26,296,000
999,000
999,000
1,748,000
2,248,000
2,747,000
2,748,000
2,498,000
1,999,000
2,498,000
2,499,000
1,999,000
2,999,000
1,498,000
2,757,000
2,259,000
2,261,000
2,511,000
1,516,000
1,025,000
1,021,000
2,270,000
2,273,000
2,283,000
4,037,000
1,793,000
1,798,000
3,667,000
1,810,000
1,810,0003,667,0001,798,0001,793,0004,037,0002,283,0002,273,0002,270,0001,021,0001,025,0001,516,0002,511,0002,261,0002,259,0002,757,0001,498,0002,999,0001,999,0002,499,0002,498,0001,999,0002,498,0002,748,0002,747,0002,248,0001,748,000999,000999,00026,296,00015,93826,346,000700,000700,0001,745,000982,000000483,0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
300
0
0
0
400
500
300
1,200
1,100
900
1,000
900
1,100
700
600
800
1,000
700
900
800
1,100
1,900
2,500
3,500
2,300
1,600
3,300
3,500
3,700
2,700
3,400
3,500
3,600
10,800
9,500
6,570
4,658
6,704
11,605
9,908
12,146
15,261
19,174
9,526
12,488
17,254
24,406
24,096
23,638
24,685
35,649
28,105
29,986
33,551
47,552
35,862
57,704
33,134
61,083
60,209
153,817
207,806
367,029
297,267
265,264
264,496
290,333
396,208
606,245
631,525
601,200
578,362
649,999
742,684
810,544
949,084
1,066,433
950,813
803,025
981,631
1,102,319
1,063,723
1,206,052
1,339,257
1,367,353
1,319,670
1,327,339
1,356,372
1,390,641
1,350,402
1,255,914
1,234,507
1,162,307
1,182,917
955,000
1,011,000
1,571,000
1,239,000
1,178,000
945,000
1,122,000
1,052,000
1,206,000
944,000
819,000
696,000
814,000
711,000
623,000
580,000
790,000
577,000
617,000
632,000
713,000
590,000
532,000
527,000
844,000
570,000
608,000
585,000
705,000
583,000
565,000
614,000
905,000
627,000
622,000
586,000
550,000
622,000
537,000
537,000622,000550,000586,000622,000627,000905,000614,000565,000583,000705,000585,000608,000570,000844,000527,000532,000590,000713,000632,000617,000577,000790,000580,000623,000711,000814,000696,000819,000944,0001,206,0001,052,0001,122,000945,0001,178,0001,239,0001,571,0001,011,000955,0001,182,9171,162,3071,234,5071,255,9141,350,4021,390,6411,356,3721,327,3391,319,6701,367,3531,339,2571,206,0521,063,7231,102,319981,631803,025950,8131,066,433949,084810,544742,684649,999578,362601,200631,525606,245396,208290,333264,496265,264297,267367,029207,806153,81760,20961,08333,13457,70435,86247,55233,55129,98628,10535,64924,68523,63824,09624,40617,25412,4889,52619,17415,26112,1469,90811,6056,7044,6586,5709,50010,8003,6003,5003,4002,7003,7003,5003,3001,6002,3003,5002,5001,9001,1008009007001,0008006007001,1009001,0009001,1001,200300500400000300000
       Other Current Liabilities 
0
0
0
1,200
0
0
0
1,700
900
3,700
3,300
4,600
3,400
6,300
5,800
6,600
4,400
7,200
6,600
6,900
5,900
7,100
11,300
10,600
11,300
10,000
17,900
16,100
16,800
28,200
32,000
27,300
27,800
27,600
25,000
22,600
42,400
35,200
33,086
37,083
41,052
43,599
39,526
39,819
50,117
55,455
54,096
52,380
60,804
72,600
100,831
104,671
101,473
144,633
14,544
16,368
167,625
185,841
219,084
187,506
222,989
315,696
288,439
280,334
297,151
360,723
385,284
467,250
394,136
414,909
501,407
502,663
581,349
571,198
629,522
675,916
891,590
932,779
809,239
798,700
911,115
912,405
1,036,668
1,137,934
1,090,448
1,232,501
1,396,883
1,552,845
1,652,535
1,670,029
1,866,663
1,946,153
1,960,065
4,895,143
4,522,710
4,903,531
4,727,773
4,514,000
6,215,000
6,846,000
7,761,000
8,271,000
7,691,000
8,277,000
8,960,000
9,219,000
8,282,000
7,673,000
9,597,000
11,635,000
10,670,000
10,912,000
10,116,000
10,605,000
9,397,000
8,961,000
9,567,000
6,547,000
6,290,000
7,033,000
7,484,000
7,796,000
6,876,000
7,345,000
7,149,000
9,389,000
6,950,000
7,634,000
7,539,000
8,059,000
7,618,000
13,964,000
7,478,000
11,280,000
13,015,000
7,696,000
7,696,00013,015,00011,280,0007,478,00013,964,0007,618,0008,059,0007,539,0007,634,0006,950,0009,389,0007,149,0007,345,0006,876,0007,796,0007,484,0007,033,0006,290,0006,547,0009,567,0008,961,0009,397,00010,605,00010,116,00010,912,00010,670,00011,635,0009,597,0007,673,0008,282,0009,219,0008,960,0008,277,0007,691,0008,271,0007,761,0006,846,0006,215,0004,514,0004,727,7734,903,5314,522,7104,895,1431,960,0651,946,1531,866,6631,670,0291,652,5351,552,8451,396,8831,232,5011,090,4481,137,9341,036,668912,405911,115798,700809,239932,779891,590675,916629,522571,198581,349502,663501,407414,909394,136467,250385,284360,723297,151280,334288,439315,696222,989187,506219,084185,841167,62516,36814,544144,633101,473104,671100,83172,60060,80452,38054,09655,45550,11739,81939,52643,59941,05237,08333,08635,20042,40022,60025,00027,60027,80027,30032,00028,20016,80016,10017,90010,00011,30010,60011,3007,1005,9006,9006,6007,2004,4006,6005,8006,3003,4004,6003,3003,7009001,7000001,200000
   > Long-term Liabilities 
0
0
0
500
0
0
0
700
800
1,000
1,100
1,100
1,400
2,000
2,700
2,500
6,900
6,500
6,200
5,400
4,700
4,200
2,700
2,100
1,400
2,900
2,200
1,900
1,600
1,400
1,100
900
700
600
400
200
92,600
91,600
90,606
89,700
9,183
268,737
268,003
265,557
263,052
262,232
261,711
257,244
267,922
611,950
611,576
611,267
616,407
365,853
367,636
366,475
372,878
31,637
35,797
34,893
33,954
273,375
216,169
1,473,766
1,418,473
1,452,896
1,464,325
1,473,312
1,482,691
1,498,152
1,500,505
200,763
1,421,448
1,452,085
1,240,834
1,295,241
1,295,574
1,321,770
1,305,675
690,985
2,986,711
3,005,843
4,043,228
4,171,968
4,182,261
7,920,995
8,398,398
7,431,889
7,411,519
7,418,949
7,528,980
6,343,852
6,380,831
4,426,756
8,460,722
8,548,825
8,925,831
13,227,000
13,305,000
13,608,000
23,333,000
22,835,000
22,836,000
23,421,000
28,176,000
28,395,000
28,502,000
28,680,000
29,811,000
38,147,000
34,060,000
32,709,000
31,182,000
31,536,000
31,349,000
31,498,000
28,843,000
29,218,000
28,683,000
27,228,000
33,898,000
38,789,000
38,823,000
38,060,000
35,382,000
35,278,000
34,607,000
33,435,000
31,077,000
30,725,000
30,409,000
27,279,000
28,186,000
28,096,000
25,822,000
24,603,000
24,603,00025,822,00028,096,00028,186,00027,279,00030,409,00030,725,00031,077,00033,435,00034,607,00035,278,00035,382,00038,060,00038,823,00038,789,00033,898,00027,228,00028,683,00029,218,00028,843,00031,498,00031,349,00031,536,00031,182,00032,709,00034,060,00038,147,00029,811,00028,680,00028,502,00028,395,00028,176,00023,421,00022,836,00022,835,00023,333,00013,608,00013,305,00013,227,0008,925,8318,548,8258,460,7224,426,7566,380,8316,343,8527,528,9807,418,9497,411,5197,431,8898,398,3987,920,9954,182,2614,171,9684,043,2283,005,8432,986,711690,9851,305,6751,321,7701,295,5741,295,2411,240,8341,452,0851,421,448200,7631,500,5051,498,1521,482,6911,473,3121,464,3251,452,8961,418,4731,473,766216,169273,37533,95434,89335,79731,637372,878366,475367,636365,853616,407611,267611,576611,950267,922257,244261,711262,232263,052265,557268,003268,7379,18389,70090,60691,60092,6002004006007009001,1001,4001,6001,9002,2002,9001,4002,1002,7004,2004,7005,4006,2006,5006,9002,5002,7002,0001,4001,1001,1001,000800700000500000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,126,401
1,140,887
1,155,443
1,170,099
562,612
2,818,708
2,838,573
3,850,130
3,870,846
3,891,758
7,605,734
8,077,246
7,126,377
7,040,382
7,054,555
7,054,796
5,849,552
5,856,093
3,938,708
7,932,032
7,932,536
7,933,040
11,921,000
11,921,000
11,922,000
21,894,000
21,195,000
21,077,000
21,427,000
26,371,000
26,346,000
26,321,000
26,296,000
27,515,000
30,795,000
26,557,000
26,062,000
24,570,000
24,574,000
24,080,000
24,084,000
22,090,000
22,094,000
22,098,000
21,103,000
27,792,000
28,645,000
27,907,000
27,914,000
25,175,000
25,179,000
25,183,000
25,195,000
22,953,000
22,957,000
22,956,000
21,209,000
0
0
0
0
000021,209,00022,956,00022,957,00022,953,00025,195,00025,183,00025,179,00025,175,00027,914,00027,907,00028,645,00027,792,00021,103,00022,098,00022,094,00022,090,00024,084,00024,080,00024,574,00024,570,00026,062,00026,557,00030,795,00027,515,00026,296,00026,321,00026,346,00026,371,00021,427,00021,077,00021,195,00021,894,00011,922,00011,921,00011,921,0007,933,0407,932,5367,932,0323,938,7085,856,0935,849,5527,054,7967,054,5557,040,3827,126,3778,077,2467,605,7343,891,7583,870,8463,850,1302,838,5732,818,708562,6121,170,0991,155,4431,140,8871,126,401000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
132,609
134,417
101,498
81,933
78,040
95,291
153,379
134,865
87,168
82,728
144,015
107,729
116,263
110,331
131,107
139,663
155,667
162,738
154,765
138,966
153,552
163,720
236,000
205,000
177,000
291,000
324,000
292,000
433,000
481,000
402,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000402,000481,000433,000292,000324,000291,000177,000205,000236,000163,720153,552138,966154,765162,738155,667139,663131,107110,331116,263107,729144,01582,72887,168134,865153,37995,29178,04081,933101,498134,417132,609000000000000000000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63,831
45,767
35,875
27,382
15,000
11,000
7,000
4,000
2,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000002,0004,0007,00011,00015,00027,38235,87545,76763,831000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,590
6,322
6,049
16,499
16,062
14,146
12,300
11,843
11,381
6,947
17,629
16,677
16,308
15,939
21,017
20,530
22,305
21,171
27,585
31,404
35,538
34,600
33,663
32,725
31,787
34,349
38,052
71,957
164,325
173,312
182,691
197,531
200,505
200,763
121,594
152,231
128,968
168,840
154,687
166,327
135,576
128,373
168,003
167,270
193,098
301,122
290,503
315,261
321,152
305,512
371,137
364,394
355,781
375,985
406,078
341,038
400,963
512,434
899,976
1,097,000
1,332,000
1,643,000
1,405,000
1,638,000
1,759,000
1,994,000
1,805,000
2,049,000
2,181,000
2,384,000
2,296,000
7,352,000
7,503,000
6,647,000
6,612,000
6,962,000
6,840,000
6,933,000
6,134,000
6,498,000
6,585,000
6,125,000
6,106,000
9,536,000
10,916,000
10,146,000
10,207,000
35,278,000
9,424,000
33,435,000
31,077,000
7,301,000
0
27,279,000
0
0
0
0
000027,279,00007,301,00031,077,00033,435,0009,424,00035,278,00010,207,00010,146,00010,916,0009,536,0006,106,0006,125,0006,585,0006,498,0006,134,0006,933,0006,840,0006,962,0006,612,0006,647,0007,503,0007,352,0002,296,0002,384,0002,181,0002,049,0001,805,0001,994,0001,759,0001,638,0001,405,0001,643,0001,332,0001,097,000899,976512,434400,963341,038406,078375,985355,781364,394371,137305,512321,152315,261290,503301,122193,098167,270168,003128,373135,576166,327154,687168,840128,968152,231121,594200,763200,505197,531182,691173,312164,32571,95738,05234,34931,78732,72533,66334,60035,53831,40427,58521,17122,30520,53021,01715,93916,30816,67717,6296,94711,38111,84312,30014,14616,06216,4996,0496,3226,59000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,417
44,567
43,026
41,489
39,526
39,446
32,844
30,275
27,706
34,704
31,870
26,506
23,662
20,836
20,532
150,607
147,083
144,058
105,265
81,960
67,980
65,433
51,000
41,000
36,000
30,000
400,000
0
0
0
423,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,464,000
4,374,000
4,603,000
4,356,000
3,687,000
3,364,000
3,036,000
2,673,000
2,401,000
2,106,000
0
0
0
0
00002,106,0002,401,0002,673,0003,036,0003,364,0003,687,0004,356,0004,603,0004,374,0004,464,0000000000000000000423,000000400,00030,00036,00041,00051,00065,43367,98081,960105,265144,058147,083150,60720,53220,83623,66226,50631,87034,70427,70630,27532,84439,44639,52641,48943,02644,56753,417000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
10,200
0
0
0
105,600
104,000
101,600
138,700
139,400
135,200
129,600
123,400
115,300
108,700
102,000
94,500
86,100
79,500
160,800
297,700
287,300
297,900
291,700
285,300
330,600
325,800
317,300
311,400
300,500
284,700
270,500
258,900
244,900
299,800
297,300
301,043
302,207
376,100
351,124
334,340
314,415
298,139
452,437
456,944
476,036
522,829
571,341
201,182
327,006
418,332
1,002,974
1,132,097
1,267,163
1,395,272
1,870,872
2,063,352
2,392,774
2,618,330
3,027,778
3,388,413
3,197,914
3,298,830
1,815,718
2,382,679
2,489,063
2,981,845
3,459,990
3,329,482
3,772,225
4,165,910
4,152,487
4,804,089
5,313,969
5,752,157
6,367,065
7,502,672
6,700,000
5,878,772
5,863,729
6,175,361
6,211,331
6,233,206
6,738,856
7,364,084
8,083,387
8,750,162
9,550,869
10,392,473
11,343,384
11,192,473
11,744,501
13,702,194
16,429,342
13,863,610
15,819,000
17,588,000
16,634,000
17,944,000
19,113,000
14,019,000
16,115,000
17,360,000
19,363,000
20,917,000
23,091,000
25,254,000
20,501,000
20,651,000
21,734,000
23,007,000
21,534,000
22,091,000
22,751,000
20,736,000
22,650,000
22,179,000
18,142,000
17,471,000
18,221,000
18,964,000
19,710,000
21,471,000
21,064,000
19,915,000
20,236,000
21,057,000
21,209,000
20,939,000
21,094,000
22,242,000
22,749,000
17,539,000
18,281,000
18,281,00017,539,00022,749,00022,242,00021,094,00020,939,00021,209,00021,057,00020,236,00019,915,00021,064,00021,471,00019,710,00018,964,00018,221,00017,471,00018,142,00022,179,00022,650,00020,736,00022,751,00022,091,00021,534,00023,007,00021,734,00020,651,00020,501,00025,254,00023,091,00020,917,00019,363,00017,360,00016,115,00014,019,00019,113,00017,944,00016,634,00017,588,00015,819,00013,863,61016,429,34213,702,19411,744,50111,192,47311,343,38410,392,4739,550,8698,750,1628,083,3877,364,0846,738,8566,233,2066,211,3316,175,3615,863,7295,878,7726,700,0007,502,6726,367,0655,752,1575,313,9694,804,0894,152,4874,165,9103,772,2253,329,4823,459,9902,981,8452,489,0632,382,6791,815,7183,298,8303,197,9143,388,4133,027,7782,618,3302,392,7742,063,3521,870,8721,395,2721,267,1631,132,0971,002,974418,332327,006201,182571,341522,829476,036456,944452,437298,139314,415334,340351,124376,100302,207301,043297,300299,800244,900258,900270,500284,700300,500311,400317,300325,800330,600285,300291,700297,900287,300297,700160,80079,50086,10094,500102,000108,700115,300123,400129,600135,200139,400138,700101,600104,000105,60000010,200000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45
45
47
94
94
95
96
193
195
196
197
198
200
201
202
213
214
215
432
449
451
455
457
460
463
456
459
461
466
926
929
932
921
923
921
910
906
905
902
900
902
860
815
802
791
777
757
753
758
756
758
760
760
765
763
1,534
1,538
1,526
1,514
2,000
1,000
2,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0002,0001,0002,0001,5141,5261,5381,5347637657607607587567587537577777918028158609029009029059069109219239219329299264664614594564634604574554514494322152142132022012001981971961951939695949447454500000000000000000000000000000000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,019,839
1,420,613
1,995,272
2,688,679
1,831,381
1,122,030
1,183,730
1,320,335
1,395,908
1,321,796
1,776,760
2,178,639
2,663,077
3,139,393
3,704,744
4,301,539
5,065,839
5,735,335
6,105,244
7,734,979
10,199,576
11,247,655
12,732,000
13,916,000
16,038,000
16,961,000
18,001,000
13,045,000
14,949,000
16,654,000
18,154,000
19,564,000
21,823,000
23,689,000
19,012,000
19,196,000
19,825,000
20,706,000
19,024,000
19,326,000
19,829,000
17,616,000
19,388,000
18,709,000
14,445,000
13,709,000
14,381,000
14,821,000
15,392,000
16,903,000
16,324,000
14,986,000
15,117,000
15,756,000
15,687,000
15,223,000
15,138,000
0
0
0
0
000015,138,00015,223,00015,687,00015,756,00015,117,00014,986,00016,324,00016,903,00015,392,00014,821,00014,381,00013,709,00014,445,00018,709,00019,388,00017,616,00019,829,00019,326,00019,024,00020,706,00019,825,00019,196,00019,012,00023,689,00021,823,00019,564,00018,154,00016,654,00014,949,00013,045,00018,001,00016,961,00016,038,00013,916,00012,732,00011,247,65510,199,5767,734,9796,105,2445,735,3355,065,8394,301,5393,704,7443,139,3932,663,0772,178,6391,776,7601,321,7961,395,9081,320,3351,183,7301,122,0301,831,3812,688,6791,995,2721,420,6131,019,839000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8,300
-8,300
-13,000
-13,000
-13,000
-13,000
-15,600
-15,600
-15,600
-15,600
-17,700
-17,700
-17,700
-2,700
-2,600
-3,044
-2,978
-1,676
-904
2,403
2,023
6,444
7,448
-2,492
-15,090
2,469
2,475
2,666
4,656
2,719
3,201
6,979
1,743
-158
-19,231
-868
12,185
9,197
11,448
-2,473
-15,369
6,062
2,221
-5,051
-6,050
-13,515
-4,363
-7,931
-11
17,190
41,240
111,644
23,293
-39,199
-5,758
83,473
189,624
7,485
30,911
-101,182
-133,279
-15,541
58,200
33,591
124,377
28,249
-45,615
20,806
30,371
-42,070
-124,446
-95,769
-41,460
173,962
301,000
539,000
247,000
167,000
88,000
-164,000
-46,000
-108,000
278,000
260,000
120,000
249,000
165,000
-170,000
2,000
36,000
80,000
130,000
102,000
117,000
85,000
46,000
70,000
23,000
-60,000
38,000
39,000
74,000
83,000
73,000
87,000
98,000
2,000
-20,000
10,000
31,000
28,000
69,000
93,000
93,00069,00028,00031,00010,000-20,0002,00098,00087,00073,00083,00074,00039,00038,000-60,00023,00070,00046,00085,000117,000102,000130,00080,00036,0002,000-170,000165,000249,000120,000260,000278,000-108,000-46,000-164,00088,000167,000247,000539,000301,000173,962-41,460-95,769-124,446-42,07030,37120,806-45,61528,249124,37733,59158,200-15,541-133,279-101,18230,9117,485189,62483,473-5,758-39,19923,293111,64441,24017,190-11-7,931-4,363-13,515-6,050-5,0512,2216,062-15,369-2,47311,4489,19712,185-868-19,231-1581,7436,9793,2012,7194,6562,6662,4752,469-15,090-2,4927,4486,4442,0232,403-904-1,676-2,978-3,044-2,600-2,700-17,700-17,700-17,700-15,600-15,600-15,600-15,600-13,000-13,000-13,000-13,000-8,300-8,30000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,145,814
4,264,222
4,376,651
4,568,942
4,540,630
4,575,984
4,648,286
4,726,309
4,783,439
4,809,752
4,903,143
5,100,624
5,213,910
5,435,242
5,649,850
5,829,126
5,995,025
5,189,582
5,386,735
5,746,574
5,930,987
2,143,092
2,391,000
2,724,000
0
285,000
444,000
516,000
632,000
321,000
454,000
616,000
733,000
906,000
1,264,000
1,564,000
1,844,000
2,118,000
2,282,000
2,494,000
2,684,000
2,870,000
3,051,000
3,311,000
3,511,000
3,712,000
3,880,000
4,092,000
4,271,000
4,492,000
4,661,000
4,867,000
5,031,000
5,226,000
5,550,000
5,793,000
6,008,000
0
0
0
0
00006,008,0005,793,0005,550,0005,226,0005,031,0004,867,0004,661,0004,492,0004,271,0004,092,0003,880,0003,712,0003,511,0003,311,0003,051,0002,870,0002,684,0002,494,0002,282,0002,118,0001,844,0001,564,0001,264,000906,000733,000616,000454,000321,000632,000516,000444,000285,00002,724,0002,391,0002,143,0925,930,9875,746,5745,386,7355,189,5825,995,0255,829,1265,649,8505,435,2425,213,9105,100,6244,903,1434,809,7524,783,4394,726,3094,648,2864,575,9844,540,6304,568,9424,376,6514,264,2224,145,814000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000-7,502,672-6,505,158-5,752,157-5,313,969000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
100
0
0
0
119,900
120,000
120,400
161,300
167,800
168,300
168,500
169,100
169,400
169,900
170,300
171,000
171,400
172,800
262,500
421,300
423,000
432,600
439,200
440,700
483,300
488,900
495,400
496,900
500,800
502,600
506,800
510,900
512,000
742,800
749,100
759,035
764,319
854,472
857,942
859,572
872,415
876,913
898,533
916,828
928,806
937,282
950,308
1,018,010
1,041,471
1,061,637
1,453,203
1,464,119
1,492,961
1,509,514
1,893,926
1,910,928
2,031,326
2,080,636
2,206,228
2,318,077
2,386,379
2,518,025
2,704,399
2,885,295
3,014,062
3,115,987
3,214,341
3,371,108
3,505,878
3,616,798
3,727,463
4,018,583
4,145,814
4,264,222
4,376,651
4,568,942
4,540,630
4,575,984
4,648,286
4,726,309
4,783,439
4,809,752
4,903,143
5,100,624
5,213,910
5,435,242
5,649,850
5,829,126
5,995,025
5,189,582
5,386,735
5,746,574
5,930,987
2,143,092
2,391,000
2,724,000
347,000
285,000
444,000
516,000
632,000
321,000
454,000
616,000
733,000
906,000
1,264,000
1,564,000
1,844,000
2,118,000
2,282,000
2,494,000
2,684,000
2,870,000
3,051,000
3,311,000
3,511,000
3,712,000
3,880,000
4,092,000
4,271,000
4,492,000
4,661,000
4,855,000
5,031,000
5,202,000
5,519,000
5,735,000
5,945,000
6,208,000
6,416,000
6,813,000
7,022,000
7,022,0006,813,0006,416,0006,208,0005,945,0005,735,0005,519,0005,202,0005,031,0004,855,0004,661,0004,492,0004,271,0004,092,0003,880,0003,712,0003,511,0003,311,0003,051,0002,870,0002,684,0002,494,0002,282,0002,118,0001,844,0001,564,0001,264,000906,000733,000616,000454,000321,000632,000516,000444,000285,000347,0002,724,0002,391,0002,143,0925,930,9875,746,5745,386,7355,189,5825,995,0255,829,1265,649,8505,435,2425,213,9105,100,6244,903,1434,809,7524,783,4394,726,3094,648,2864,575,9844,540,6304,568,9424,376,6514,264,2224,145,8144,018,5833,727,4633,616,7983,505,8783,371,1083,214,3413,115,9873,014,0622,885,2952,704,3992,518,0252,386,3792,318,0772,206,2282,080,6362,031,3261,910,9281,893,9261,509,5141,492,9611,464,1191,453,2031,061,6371,041,4711,018,010950,308937,282928,806916,828898,533876,913872,415859,572857,942854,472764,319759,035749,100742,800512,000510,900506,800502,600500,800496,900495,400488,900483,300440,700439,200432,600423,000421,300262,500172,800171,400171,000170,300169,900169,400169,100168,500168,300167,800161,300120,400120,000119,900000100000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue27,116,000
Cost of Revenue-5,804,000
Gross Profit27,116,00021,312,000
 
Operating Income (+$)
Gross Profit27,116,000
Operating Expense-11,808,000
Operating Income7,605,00015,308,000
 
Operating Expense (+$)
Research Development5,718,000
Selling General Administrative6,502,000
Selling And Marketing Expenses826,000
Operating Expense11,808,00013,046,000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-944,000
Other Finance Cost-26,000
Net Interest Income-918,000
 
Pretax Income (+$)
Operating Income7,605,000
Net Interest Income-918,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)6,859,0008,351,000
EBIT - interestExpense = 6,661,000
4,418,000
6,609,000
Interest Expense944,000
Earnings Before Interest and Taxes (EBIT)7,605,0007,803,000
Earnings Before Interest and Taxes (EBITDA)7,605,000
 
After tax Income (+$)
Income Before Tax6,859,000
Tax Provision-1,408,000
Net Income From Continuing Ops5,829,0005,451,000
Net Income5,665,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses19,511,000
Total Other Income/Expenses Net-746,000918,000
 

Technical Analysis of Gilead
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gilead. The general trend of Gilead is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gilead's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gilead Sciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 89.74 > 82.39 > 81.83.

Tweet this
Gilead Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gilead Sciences Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gilead Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gilead Sciences Inc. The current macd is 1.62222185.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gilead price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Gilead. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Gilead price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Gilead Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartGilead Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gilead Sciences Inc. The current adx is 45.89.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Gilead shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Gilead Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gilead Sciences Inc. The current sar is 86.83.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Gilead Sciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gilead Sciences Inc. The current rsi is 69.88. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Gilead Sciences Inc Daily Relative Strength Index (RSI) ChartGilead Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gilead Sciences Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gilead price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Gilead Sciences Inc Daily Stochastic Oscillator ChartGilead Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gilead Sciences Inc. The current cci is 139.51.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Gilead Sciences Inc Daily Commodity Channel Index (CCI) ChartGilead Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gilead Sciences Inc. The current cmo is 43.19.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Gilead Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartGilead Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gilead Sciences Inc. The current willr is -17.02544031.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Gilead Sciences Inc Daily Williams %R ChartGilead Sciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Gilead Sciences Inc.

Gilead Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gilead Sciences Inc. The current atr is 1.41137743.

Gilead Sciences Inc Daily Average True Range (ATR) ChartGilead Sciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gilead Sciences Inc. The current obv is 183,958,543.

Gilead Sciences Inc Daily On-Balance Volume (OBV) ChartGilead Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gilead Sciences Inc. The current mfi is 71.79.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Gilead Sciences Inc Daily Money Flow Index (MFI) ChartGilead Sciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gilead Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Gilead Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gilead Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5069.876
Ma 20Greater thanMa 5087.272
Ma 50Greater thanMa 10084.011
Ma 100Greater thanMa 20077.917
OpenGreater thanClose89.490
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Gilead with someone you think should read this too:
  • Are you bullish or bearish on Gilead? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gilead? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gilead Sciences Inc

I send you an email if I find something interesting about Gilead Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Gilead Sciences Inc.

Receive notifications about Gilead Sciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.